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Summary The Ca antigen, which can be detected in a wide range of malignant human tumours by means of
the Cal antibody, is a glycoprotein of the mucin type. At least 95% of the carbohydrate is 0-glycosidically
linked to the polypeptide which contains high proportions of glycine, serine and glutamic acid. The
carbohydrate has a very simple structure: it is composed almost entirely of tetra- tri- and disaccharides having
the general formula (NeuNac) -+[Gal-.GalNac]4, where n=O, 1 or 2. In many malignant cell lines, the
antigen is produced constitutively in vitro; but in one that has been examined, its synthesis can be induced by
high concentrations of lactate. Evidence is presented for the view that a primary function of this glycoprotein
is to shield the cells that produce it from hydrogen ion concentrations outside of the physiological range. The
presence of the Ca antigen in malignant tumours may thus be a reflection of metabolic conditions that are
known to be characteristics of such tumours.
We have recently described an antigen (Ashall et
al., 1982), the Ca antigen, which is defined by a
monoclonal IgM antibody, Cal, and which has the
following properties:
1. It is found on the surface of a wide range of
malignant human cell lines, but not on diploid
human cell strains.
2. It is not expressed in hybrids between malignant
and non-malignant human cells where
malignancy is suppressed, but it reappears in
malignant segregants derived from these
suppressed hybrids.
3. It is either not present, or present in very low
concentrations, in homogenates of normal adult
or foetal human tissues.
4. Preparations of the antigen purified by
immunoprecipitation with the Cal antibody
separate in electrophoresis as two components
with apparent molecular masses of 390,000
and 350,000. These components have the
characteristics of glycoproteins with a high
carbohydrate content. Their antigenicity is
unaffected by boiling or extraction by the
common organic solvents, but is partly
destroyed by neuraminidase and completely
destroyed by prolonged digestion with Pronase
(Ashall et al., 1982).
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5. In immunohistological tests (McGee et al., 1982;
Woods et al., 1982) the antigen was found on
the cells of the majority of malignant human
tumours but not on those of a range of benign
tumours. Of the normal tissues examined in this
way, the Cal antibody was found to bind,
apparently specifically, to two: the transitional
epithelium of the urinary tract and the luminal
epithelium of the fallopian tube.
In the present paper we present further
information about the structure of the Ca antigen
based on the analysis of preparations purified by
affinity chromatography and high performance
liquid chromatography; and we describe some
investigations which, together with the structural
information presented, permit us to propose a
function for the antigen and an explanation for its
presence in the cells ofmalignant tumours.
Structure
We present a summary of the information we have
so far obtained. Fuller details of the chemical
structure of the Ca antigen will be reported
elsewhere.
Malignant cells growing in vitro shed the antigen
into the medium, so that both cells and medium
may serve as starting material for purification
proceduras. The structural studies presented here
were done on preparations of the Ca antigen
isolated from deoxycholate extracts of Hep 2 cells
by affinity chromatography on columns of Cal
antibody coupled to Sepharose 4B beads (Ashall et
al., 1982). The antigen eluted from the affinity
columns was further purified by high performance
liquid chromatography (Ashall et al., 1982), gel
filtration and chromatography on wheat germ
agglutinin-Sepharose columns. The elution pattern
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of the purified antigen on Sepharose 4B and Bio-
Gel A-1.5m columns confirmed its high molwt. (on
both columns the Ca antigen eluted before
thyroglobulin) and showed the microheterogeneity
characteristic of glycoproteins with a high
carbohydrate content. The antigen eluted as a
single homogeneous peak on a column of DEAE-
Sepharose, and its elution position excludes the
possibility that it is either sulphated or
phosphorylated. The isoelectric point of the purified
antigen determined by electro-focussing in
ampholines was found to be 6.3-6.8. After removal
of sialic acids by neuraminidase treatment the
isoelectric point was changed to -7.8. We do not
yet have a satisfactory explanation for this
unexpectedly high isoelectric point, but are
pursuing the matter further. As shown in Table I, it
cannot be accounted for by the amino acid
composition of the polypeptide moiety of the
antigen.
Table I Amino acid composition of the Ca
antigen
Mol.%
Cys
Asp
Thr
Ser
Glu
Pro
Gly
Ala
Val
Met
Ileu
Leu
Tyr
Phe
His
Lys
Arg
1.1
6.7
4.3
16.3
14.2
4.3
17.7
6.9
3.6
0.6
1.9
3.5
1.6
2.6
3.0
8.8
2.5
Conditions of hydrolysis: 6NHCl for 24h at
110°C in vacuo in sealed tubes. The analysis was
done with an LKB 4400 amino analyser (LKB
Instruments, Croydon, U.K.).
On the basis of dry mass measured before and
after deglycosylation by treatment with
trifluoromethane sulphonic acid (Edge et al., 1981),
purified preparations of the Ca antigen were found
to consist of about two-thirds polysaccharide and
one-third polypeptide. When [1251]-labelled Ca
antigen was treated with this reagent and the
product subjected to polyacrylamide gel
electrophoresis in the presence of sodium dodecyl
sulphate (SDS), a diffuse band with an apparent
molecular mass of 50-60,000 was detected. This
confirms that the antigen has a high carbohydrate
content, but further work will be required to
determine the true size of the protein core. Acid
hydrolysis of the purified antigen yielded the amino
acid composition shown in Table I.
Analysis of purified preparations of the Ca
antigen isolated from Hep 2 cells grown in the
presence of radioactive precursor sugars ([3H]-
glucosamine, ['4C]-glucose, [14C]-galactose and [3H]-
mannose) provided the following information about
the composition and structure of the carbohydrate
moiety. The major sugars present were sialic acid,
N-acetylgalactosamine (GalNac) and galactose
(Gal). A small amount of N-acetylglucosamine,
-5% of the total hexosamine content, was also
present, but this might have been due to trace
amounts of contaminating glycoproteins. The sialic
acid was completely susceptible to V. cholerae and
A. ureafaciens neuraminidase, but was only partially
hydrolysed by Newcastle Disease virus
neuraminidase. This suggests that the sialic acid
may also be present in linkages other than ax2--3.
The interaction of the glycoprotein with wheat
germ agglutinin indicated that the sialic acid was
probably all N-acetylneuraminic acid (NeuNac).
Treatment of the desialylated Ca antigen with D.
pneumoniae endo-a-N-acetylgalactosaminidase
(Umemoto et al., 1977) resulted in the release of
90% of the radioactivity as an oligosaccharide
that co-chromatographed with [Galp/l-3 GalNac]
on Bio-Gel P-4 and P-6 columns. Mild alkaline
borohydride treatment (Bhavanandan et al., 1981)
of the antigen released 95% of the radioactivity as
oligosaccharides. Analysis of these oligosaccharides
by high voltage paper electrophoresis and by
chromatography on Bio Gel P-4 and P-6 columns
revealed that the major components had mobilities
identical with the tetrasaccharide [(NeuNac)2
-*Gal-+GalNac (OH)], the trisaccharide [NeuNac
-+Gal-+GalNac (OH)] and the disaccharide [Gal
-*GalNac (OH)] isolated from fetuin (Spiro &
Bhoyroo, 1974). The distribution of radioactivity in
these three oligosaccharides was in the ratio 5:7:1.
Exhaustive treatment of the Ca antigen with
Pronase yielded glycopeptides that were non-
dialysable and were excluded from a Bio-Gel P-10
column. On a Bio-Gel A-1.5m column the
glycopeptides eluted as two partially separated
peaks with molecular masses of 28,000 and 14,500.
The high apparent molecular masses of these
glycopeptides suggested that the oligosaccharides
probably occurred as clusters along the polypeptide
chain. It is clear that the Ca antigen has the typical
features of a glycoprotein of the mucin type in
which the oligosaccharides are 0-glycosidically
linked to the polypeptide chain.STRUCTURE AND FUNCTION OF THE Ca ANTIGEN 179
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Our studies on the function of the Ca antigen
began with the observation that, in
immunohistological tests, the Cal antibody reacted
with the transitional epithelium of the urinary tract
and the luminal epithelium of the fallopian tube
(McGee et al., 1982). These epithelia were not
stained by a panel of other monoclonal IgM
antibodies so that the reaction with Cal appeared
to be specific. It was essential to determine, in the
first instance, whether these epithelia did indeed
express the Ca antigen. Of the two, the urothelium
appeared the more promising for chemical studies,
for whereas the luminal epithelium of the fallopian
tube is only one or two cells deep, the urothelium
contains several layers of cells. This permits it to be
stripped away from the bladder or ureter so that
contamination of the epithelial cell extracts with
extracts of other cell types is greatly reduced.
Specimens of human bladder, ureter and kidney
pelvis were obtained at operation and frozen at
once in liquid nitrogen. For preparation of the Ca
antigen, the samples were thawed rapidly in PBS.
The cells of the urothelium were scraped off,
washed in PBS and spun down. The pellet, which
consisted largely of dispersed cells, was extracted
with sodium deoxycholate as previously described
(Ashall et al., 1982). The extract was heated on a
boiling water bath for 5min and the denatured
proteins removed by centrifugation. The
supernatant was applied directly to a Cal antibody-
Sepharose 4B affinity column and the bound
material recovered as described (Ashall et al., 1982).
This was subjected to SDS polyacrylamide gel
electrophoresis. The position of the Ca antigen was
identified by affinity labelling of the gel with [1251]_
wheat germ agglutinin followed by autoradiography
(Ashall et al., 1982). Figure 1 shows that the pair of
wheat germ agglutinin-binding components with
apparent molecular masses of 390,000 and 350,000
that characterize the Ca antigen are present in the
extract of urothelium. The Ca antigen prepared in
the same way from Hep 2 cells is shown for
comparison. (As previously described (Ashall et al.,
1982), the wheat germ agglutinin-binding patterns
of the Ca antigen from different sources show some
microheterogeneity on electrophoresis.) Figure 1
also shows that the Ca antigen is shed into the
urine. To prepare the antigen from urine, 2 litres of
freshly shed urine were concentrated 50 times in an
AMICON concentrator with an XM300 filter,
dialysed and freeze dried. The freeze dried sample
was taken into solution and the Ca antigen purified
in the usual way on a Cal antibody-Sepharose 4B
column. We conclude that the staining of the
urothelium by the Cal antibody is not a cross-
reaction with some other cellular component, but
*- 390,000
.-350,000
Figure 1 SDS acrylamide-gel electrophoresis of the
Ca antigen recovered from (a) bladder urothelium (b)
urine (c) Hep-2 cells. Material binding to the Cal
antibody-Sepharose 4B column was eluted and
subjected to electrophoresis on a 4-12% gradient gel
for 2.5 h at 200 V. The gels were affinity labelled with
[1251]-wheat germ agglutinin and subjected to
autoradiography as previously described (Ashall et al.,
1982). Molecular mass markers are shown on the
right.
reveals the presence in this epithelium of the Ca
antigen.
We then explored the distribution of the Ca
antigen in the layers of the urothelium by
immunohistological tests on freshly isolated surgical
samples of bladder and ureter. The distribution of
the antigen as revealed by staining with the Cal
antibody is shown in Figure 2. It will be seen that
the antigen is not expressed in the basal, generative,
layers of the epithelium. Its synthesis is initiated in
the intermediate, pyriform, layer (Hicks, 1975),
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Figure 2 Immunoperoxidase reaction with the Cal antibody on the urothelium of human bladder. Paraffin
sections were prepared from a freshly isolated surgical specimen and stained as described in McGee et al.
(1982). The Ca antigen is not present in the basal, generative, layer of the epithelium, but makes its
appearance in the intermediate layer; it is present in highest concentrations on the luminal surface.
where it appears to accumulate preferentially on the
luminal aspects of the cells, and it is present in
highest concentration in the cells that actually form
the luminal surface. These observations, coupled
with the information we have presented about its
structure, strongly suggest that the Ca antigen
serves a function that is classical for a mucus
glycoprotein, namely to shield the epithelium that
produces it from toxic agents that would otherwise
be destructive (Florey, 1970).
What, in the case of the urothelium, might these
toxic agents be? Since, under normal conditions, the
urine secreted by the kidney is an essentially
protein- and cell-free filtrate, we do not have to
consider a cellular or enzymic attack on the
urothelium under physiological conditions. The
literature provides little information about the
cytotoxicity for epithelial cells of the non-volatile
solutes of the urine. We therefore made a direct test
of this. A freshly shed, mid-morning sample of
urine was added in a range of concentrations from
0-25% (v/v) to cultures of HeLa cells growing
exponentially in Dulbecco's minimum essential
medium with 10% foetal calf serum; the pH of the
medium remained within the physiological range. It
was found that the growth of the cells was
unimpaired by a 15% concentration of urine in the
medium; and even at a concentration of 20%, with
no correction being made for changes in the
osmolarity of the medium, the cells grew at an only
slightly reduced rate for 24h. It thus appears that
the non-volatile solutes of normal urine have little
acute cytotoxicity for epithelial cells. However, the
pH of shed urine usually lies within the range 4.5-
6.0 (Bouchier & Morris, 1982). Hydrogen ion
concentrations below pH5.0 are rapidly lethal to
almost all mammalian cells in vitro . It is therefore
difficult to avoid the conclusion that one function
of the mucus glycoprotein that lines the urothelium
must be to shield the epithelial cells from extremes
of pH. There are reasons for supposing that this
function might not be limited to the Ca antigen on
the urothelium. It has been found that the Cal
antibody reacts, apparently specifically, with the
luminal epithelium of the fallopian tube (McGee et
al., 1982). We are not aware of any systematic
measurements of the pH of the contents of the
human oviduct under physiological conditions; but,
in the sheep, it appears that, during the oestrus
cycle, the pH of the oviduct contents fluctuates inSTRUCTURE AND FUNCTION OF THE Ca ANTIGEN 181
the acid range reaching values of at least 6.0
(Hadek, 1953). Further studies on the localization
of the Ca antigen in histological sections of adult
human tissues have recently revealed that the Cal
antibody also reacts, apparently specifically, with
the epithelium of apocrine sweat glands and- the
ducts of eccrine sweat glands (McGee, personal
communication); the pH of sweat may fall to well
below 5.0 (Kaiser et al., 1974). We attempted to
make a simple test of the ability of the Ca antigen
to protect cells against extremes of pH by
comparing the survival at pH 4.5 and pH 5.0 of cell
types that produced the antigen in vitro and of
those that did not. We found, however, that even
among cells that did not produce the antigen there
were wide differences in their resistance to this pH
range. We are at present attempting to select from
the one cell type variants that produce the antigen
at high levels in vitro and others that do not
produce it. This may lead to a more interpretable
experiment.
We thought it unlikely, in any case, that the high
hydrogen ion concentration was itself the inducer of
Ca antigen synthesis, for, in the urothelium, this
synthesis begins in the intermediate layer which is
at some distance from the lumen and already
shielded from the urine. It seemed to us that a
more promising candidate for this role was lactic
acid. High lactate concentrations are characteristics
of the secretions of the oviduct (Hamner &
Williams, 1965; Restall & Wales, 1966; Mastroianni
et al., 1958) and of the sweat glands (Kaiser et al.,
1974), where it appears that the lactate is generated
by the glycolytic activity of the epithelial cells
themselves (Mastroianni et al., 1958). This is
probably also true of the cells of the urothelium,
for although the renal threshold for lactate is only
exceeded during severe excercise, some 75 mg of
lactate are nonetheless normally excreted in the
urine each day (Long, 1961). We tested the effect of
high concentrations of sodium lactate on a range of
cell types growing in vitro. In Hep 2 and HeLa
cells, which produce the Ca antigen in large
amounts (Ashall et al., 1982), only marginal effects
were observed; but in RT112/84 cells, a human
bladder carcinoma cell line that makes only very
small amounts of the antigen in vitro (Ashall et al.,
1982), high concentrations of sodium lactate
induced a dramatic increase in the amount of
antigen produced. This increase was obvious within
24h and continued to rise for at least 96h. Table II
shows the results of one such experiment: after 48 h
in 10mgml- 1 of sodium lactate, the RT112/84 cells
show a more than 20-fold increase in the amount
of Ca antigen on the cell surface.
Immunocytochemical tests on preparations of fixed
cells showed that the increase in Ca antigen
production involved not only the antigen on the
Table II Effect of lactate on the amount of Ca
antigen on the cell surface
Amount of2nd antibody bound
Target (c.p.m. x 105per cell)
RT112/84 cells 577
No lactate 567
RT112/84 cells 11854
+lactate 12174
RTI 12/84 cells were grown in Dulbecco's minimum
essential medium with 10% fetal calf serum. The
medium in the experimental culture contained
sodium lactate (racemic) at a concentration of
l0mgml-1. The medium in both experimental and
control cultures was changed at 24h. At 48h, the
cells were harvested in PBS containing 0.02%
EDTA. The washed cells (2 x 105 per well) served
as the targets in an indirect radioimmunoassay
with Cal as the 1st antibody. The assay was done
under saturating conditions as described by
Williams (1977). Duplicate measurements are
shown, corrected for background.
surface of the cell, but also that within the cell
cytoplasm. Diploid human fibroblasts, which do
not make the Ca antigen at all, cannot be induced
to do so by high lactate concentrations. It thus
appears that some malignant cells synthesize the Ca
antigen constitutively in vitro, whereas others can
be induced to do so by high concentrations of
lactate.
Role of the Ca antigen in malignant cells
We are now in a position to suggest an explanation
for the presence of the Ca antigen in the cells of a
wide range of different malignant tumours. The
environmental problems confronted by the cells of
a malignant tumour are not unlike those
confronted by the specialized epithelia we have
discussed. The high glycolytic activity of malignant
cells generates large amounts of lactate and this
accumulates within the tumour because it fails to be
effectively removed by an impaired, or even absent,
microcirculation (Peterson, 1979; Hirst et al., 1982).
The accumulation of lactate is associated with a
progressive fall in the extracellular pH: a recent
study done with non-disruptive microelectrodes
records a range of extracellular pH values from 7.2
to 5.8 (Vaupel et al., 1981). If we accept that the
Ca antigen serves to shield certain specialized
normal epithelia from excessive concentrations of
hydrogen ions, then it is reasonable to propose that
it serves a similar function in malignant cells. Its
presence can thus be regarded as one manifestation
of a metabolic pattern that is known to be
characteristic ofmany malignant tumours.182 M.E. BRAMWELL et al.
This view of the biological role of the Ca antigen
and the mechanism of its induction implies that the
antigen could be induced in malignant tumours
before they have invaded surrounding tissues or
undergone metastasis; and this is borne out by the
results that have been obtained in
immunohistochemical tests on clinical material
(McGee et al., 1982). Indeed, more recent
observations indicate that the Ca antigen can be
detected in lesions now classified as premalignant or
as carcinoma in situ (McGee, personal
communication). One further aspect of the observed
pattern of development of the Ca antigen in
malignant tumours becomes comprehensible in
these terms. In some malignant tumours, the
antigen is distributed throughout the whole of the
tumour tissue; but in others it occurs only in
patches (McGee et al., 1982). It is possible that in
the former case we may be dealing with constitutive
production of the antigen by the malignant cells,
whereas, in the latter, its synthesis might be induced
by the accumulation of lactate. Recent work has
established that there is marked variation in the
lactate concentrations and pH values obtained in
different microareas within the same tumour
(Vaupel et al., 1981). Many benign tumours do not
show the antigen when their malignant homologues
do (McGee et al., 1982). A possible explanation for
this might be that lactate does not normally
accumulate to any significant extent within benign
tumours. We are not aware of any measurements of
lactate concentrations in benign tumours, but their
slow growth, usually adequate blood supply and
undegraded tissue architecture might be thought to
argue against the likelihood of lactate
accumulation, unless the lesions are complicated by
secondary changes that impair the microcirculation.
Earlier workers who found much lower pH values
in malignant tumours than in the normal tissues
surrounding them, failed to find any systematic
difference between benign tumours and
neighbouring normal tissues (Meyer et al., 1948).
Whether the presence of the Ca antigen in pre-
malignant or equivocal hyperplasias has any
prognostic significance is at present being
systematically investigated.
We do not yet have any experimental evidence
that might account for the failure of certain
malignant tumours, notably those arising in the
central nervous system and in parts of the
gastrointestinal tract, to produce the Ca antigen
(McGee et al., 1982). One possibility is that there
may be structural variants of the Ca antigen that
have the same function but are not detected by the
monoclonal Cal antibody. Such variants may
eventually be detected by other antibodies. In the
case of gastrointestinal malignancies, the protective
role proposed for the Ca antigen may be fulfilled
by other families of mucus glycoproteins which
these tumours commonly synthesize. Glycoproteins
of the mucin type have often been detected in
human malignant tumours, but there has been little
detailed investigation of their structure or function.
It could prove to be a very interesting subject.
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